Get the Stockscreener App
1.54
1.91%
-0.03
After Hours:
1.56
0.02
+1.30%
Opko Health Inc stock is traded at $1.54, with a volume of 4.44M.
It is down -1.91% in the last 24 hours and down -2.53% over the past month.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
See More
Previous Close:
$1.57
Open:
$1.565
24h Volume:
4.44M
Relative Volume:
1.11
Market Cap:
$1.04B
Revenue:
$863.49M
Net Income/Loss:
$-188.86M
P/E Ratio:
-5.7037
EPS:
-0.27
Net Cash Flow:
$-44.47M
1W Performance:
-3.14%
1M Performance:
-2.53%
6M Performance:
+24.19%
1Y Performance:
-1.28%
1-Day Range:
$1.53
$1.57
1-Week Range:
$1.53
$1.65
52-Week Range:
$0.8516
$1.76
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.54 | 1.04B | 863.49M | -188.86M | -44.47M | -0.25 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
Esoteric Testing Market is Set to Experience a Revolutionary Growth | Labcorp, Quest Diagnostics, OPKO Health - openPR
Connected Drug Delivery Devices Market is Dazzling Worldwide - openPR
OPKO Health (NASDAQ:OPK) Raised to Hold at StockNews.com - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) CEO Buys $198,750.00 in Stock - MarketBeat
Phillip Frost Buys Handful Of Shares In OPKO Health - Simply Wall St
Opko health CEO Phillip Frost buys $199,375 in stock By Investing.com - Investing.com South Africa
Opko health CEO Phillip Frost buys $199,375 in stock - Investing.com
Opko Health stock hits 52-week high of $1.75 amid growth - Investing.com Canada
Opko Health stock hits 52-week high of $1.75 amid growth By Investing.com - Investing.com South Africa
Opko health CEO Phillip Frost purchases $781,050 in shares By Investing.com - Investing.com Canada
Charles Schwab Investment Management Inc. Decreases Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Opko health CEO Phillip Frost purchases $781,050 in shares - Investing.com
Is OPKO Health (OPK) the Best NASDAQ Penny Stock to Buy Right Now? - Insider Monkey
11 Best NASDAQ Penny Stocks To Buy Right Now - Insider Monkey
NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer - Marketscreener.com
NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer – Company AnnouncementFT.com - Financial Times
Global Clinical Laboratory Tests Market Forecast for 2024 - openPR
OPKO Health (NASDAQ:OPK) investors are sitting on a loss of 59% if they invested three years ago - Yahoo Finance
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - The Eastern Progress Online
Buy, Sell, or Hold: Opko Health - AOL
Further weakness as OPKO Health (NASDAQ:OPK) drops 4.9% this week, taking three-year losses to 60% - Simply Wall St
OPKO Health, Inc. (NASDAQ:OPK) CEO Purchases $304,580.16 in Stock - MarketBeat
Opko health CEO Phillip Frost buys $305,376 in shares By Investing.com - Investing.com Australia
Opko health CEO Phillip Frost buys $305,376 in shares - Investing.com
Tranche Update on OPKO Health, Inc.'s Equity Buyback Plan announced on July 18, 2024. - Marketscreener.com
Rubric Capital Management LP Increases Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Opko health CEO Phillip Frost buys $159k in common stock - Investing.com India
Opko health CEO Phillip Frost buys $159k in common stock By Investing.com - Investing.com South Africa
Phillip Md Et Al Frost Acquires 100,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
OPKO Health To Participate In The Piper Sandler 36th Annual Healthcare Conference - Barchart
OPKO Health (OPK) Q3 Earnings Surpass Estimates - MSN
NextPlat (NASDAQ: NXPL) Expands OPKO Product Promotion at Asia’s Largest Health Expo - The Globe and Mail
Hyperparathyroidism Treatment Market Growth Trends, Regional - openPR
NextPlat to Showcase OPKO Healthcare Products at Major Chinese Health Expo | NXPL Stock News - StockTitan
OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts - MSN
NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo - PR Newswire
OPKO Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Opko health CEO Phillip Frost buys $161,980 in stock - Investing.com
NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results - WV News
Rubric Capital Management LP's Strategic Acquisition in OPKO Hea - GuruFocus.com
Barrington Research Estimates OPKO Health FY2028 Earnings - MarketBeat
Insider Buying: OPKO Health Chairman & CEO Bought US$422k Of Shares - Simply Wall St
OPKO Health: Q3 Earnings Snapshot - AOL
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Opko Health Inc Stock (OPK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 11 '24 |
Buy |
1.56 |
500,000 |
781,050 |
212,411,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 29 '24 |
Buy |
1.53 |
199,072 |
305,376 |
211,911,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 22 '24 |
Buy |
1.59 |
100,000 |
159,000 |
211,712,405 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 14 '24 |
Buy |
1.62 |
100,000 |
161,980 |
211,612,405 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 08 '24 |
Buy |
1.50 |
280,183 |
421,535 |
211,512,405 |
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):